Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBeth Israel Deaconess Medical Center

About this trial

This study will evaluate the influence of sleep apnea on clinical and radiological features of MS. Sleep apnea is associated with hypoxemia during sleep, which is likely detrimental to MS. Clinical data (MRI, lab results, medical history, labs, and sleep studies) of MS patients will be collected and analyzed. This will be done to study correlations between MRI, clinical data, lab studies and sleep studies. There is specific interest in the type of sleep apnea associated with MS, and whether MRI or clinical metrics of MS severity correlate with presence or absence of sleep apnea.

Eligibility criteria

Qualifiers

Written consent

Over age 18

Confirmed diagnosis of multiple sclerosis

Disqualifiers

cannot provide informed consent

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

800 Participants
are grouped into 2 trial groups